BE540293A - - Google Patents
Info
- Publication number
- BE540293A BE540293A BE540293DA BE540293A BE 540293 A BE540293 A BE 540293A BE 540293D A BE540293D A BE 540293DA BE 540293 A BE540293 A BE 540293A
- Authority
- BE
- Belgium
- Prior art keywords
- parts
- hexamethylene tetramine
- products
- acid
- tetramine
- Prior art date
Links
- VKYKSIONXSXAKP-UHFFFAOYSA-N Hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 17
- 229960004011 Methenamine Drugs 0.000 claims description 17
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 17
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 17
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbamate Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims description 3
- 239000000047 product Substances 0.000 claims 2
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 230000004526 pharmaceutical effect Effects 0.000 claims 1
- 239000002253 acid Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000002048 spasmolytic Effects 0.000 description 3
- 206010029148 Nephrolithiasis Diseases 0.000 description 2
- 206010038419 Renal colic Diseases 0.000 description 2
- 210000001635 Urinary Tract Anatomy 0.000 description 2
- 230000001396 anti-anti-diuretic Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000000249 desinfective Effects 0.000 description 2
- 230000001882 diuretic Effects 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M Sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010046566 Urinary tract disease Diseases 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 208000000207 Urologic Disease Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000001914 calming Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 230000000668 effect on calcium Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE540293A true BE540293A (de) |
Family
ID=169706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE540293D BE540293A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE540293A (de) |
-
0
- BE BE540293D patent/BE540293A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH469659A (fr) | Procédé d'obtention de dérivés du tri-hydroxy-méthyl-aminométhane | |
| BE540293A (de) | ||
| CA1312333C (fr) | Sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant | |
| CN101709042A (zh) | 无菌精氨酸谷氨酸盐及其粉针剂的制备方法 | |
| CH651032A5 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant. | |
| BE459304A (de) | ||
| BE420240A (de) | ||
| BE524378A (de) | ||
| CH402842A (fr) | Procédé de préparation de nouveaux dérivés de l'héparine | |
| BE499762A (de) | ||
| BE546149A (de) | ||
| FR2475546A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant | |
| BE425345A (de) | ||
| BE563353A (de) | ||
| BE530472A (de) | ||
| BE442066A (de) | ||
| BE572026A (de) | ||
| BE643571A (de) | ||
| BE446318A (de) | ||
| BE365387A (de) | ||
| BE486362A (de) | ||
| BE834197A (fr) | Procede de preparation de sels de magnesium d'acides phenoxyalcanoiques | |
| BE493897A (de) | ||
| BE482003A (de) | ||
| BE494006A (de) |